Chiropractors in Shenandoah, TX Accepting Medicare

9 Chiropractors found. Showing 1 - 9

Dr. Nathan Chase Banks, D.C. Chiropractor - Sports Physician Medicare: Not Enrolled in Medicare Practice Location: 118 Shenandoah Dr, Shenandoah, TX 77381 Phone: 832-444-5527

Dr. Patrick Barnett, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 614 Crestwood Dr, Shenandoah, TX 77381 Phone: 281-364-6999

Rehabilitation & Spine Associates Of Houston P.a. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 111 Vision Park Blvd, Ste # 100, Shenandoah, TX 77384 Phone: 281-362-0006    Fax: 281-362-0233

Greater Houston Physician's Medical Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 9201 Pinecroft Dr, Shenandoah, TX 77380 Phone: 281-298-2876    Fax: 281-298-2841

Robert Dean Timar, D.C. Chiropractor - Sports Physician Medicare: Medicare Enrolled Practice Location: 9000 Six Pines Dr, Shenandoah, TX 77380 Phone: 346-786-5988    Fax: 952-474-1504

Anita Balshaw, PT Chiropractor - Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 111 Vision Park Blvd, Ste 100, Shenandoah, TX 77384 Phone: 281-362-0006    Fax: 281-362-0233

Dr. Lynnette R Orrick, DC Chiropractor - Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 111 Vision Park Blvd, Suite 100, Shenandoah, TX 77384 Phone: 281-362-0006    Fax: 281-362-0233

Samer C Faysal, FNP Chiropractor Medicare: Medicare Enrolled Practice Location: 117 Vision Park Blvd, Shenandoah, TX 77384 Phone: 936-443-8460    Fax: 866-936-4875

Sandstone Neurofeedback Centers, Pllc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 8850 Six Pines Dr Ste 250, Shenandoah, TX 77380 Phone: 281-203-0070    Fax: 936-230-5162

News Archive

BioCryst to commence Phase 2 study of BCX4208 alone and in combination with allopurinol in gout patients

BioCryst Pharmaceuticals, Inc. announced it is initiating a Phase 2 study of BCX4208 alone and in combination with allopurinol in patients with gout. BioCryst recently reported positive results from part one of its Phase 2 monotherapy study of BCX4208 in patients with gout and is now moving forward as planned with an additional Phase 2 trial of BCX4208.

Study offers clues to potential treatments for preserving, restoring insulin-producing cells

In type 1 diabetes, the body relentlessly attacks and destroys its own insulin-producing pancreatic beta cells. But a study by Joslin Diabetes Center scientists now has firmly established that some of these cells endure for many decades in a small group of people with the disease—offering clues to potential treatments for preserving and even restoring the crucial cell population.

Extracellular vesicles may serve as drug delivery vehicles for cancer treatment

Creating enough nanovesicles to inexpensively serve as a drug delivery system may be as simple as putting the cells through a sieve, according to an international team of researchers who used mouse autologous - their own - immune cells to create large amounts of fillable nanovesicles to deliver drugs to tumors in mice.

Pre-clinical data demonstrates advantages of Combo Stent

OrbusNeich announced today that pre-clinical data involving porcine coronary models demonstrate that the company's Combo Bio-engineered Sirolimus Eluting Stent (Combo Stent) may offer advantages to the Cypher(R) sirolimus eluting stent and the XIENCE(TM) V everolimus eluting stent.

Best proven drug to treat schizophrenia could be safely given to African descent people

A study led by researchers at Cardiff University means that more people of African descent who have treatment-resistant schizophrenia could be safely given the drug best proven to manage their symptoms.

Read more Medical News

› Verified 4 days ago